Literature DB >> 10589746

Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions.

B K Zebrowski1, S Yano, W Liu, R M Shaheen, D J Hicklin, J B Putnam, L M Ellis.   

Abstract

Vascular endothelial growth factor (VEGF) is an important mediator of angiogenesis and vascular permeability. We hypothesized that malignant pleural effusions may contain high levels of VEGF protein as well as other cytokines implicated in these processes. Pleural effusions cytologically proven to be malignant were collected from 39 patients with various types of cancer, and VEGF, interleukin-8, and angiogenin levels in the effusions were determined by immunoassay. Negative controls were nonmalignant ascites and serum samples from healthy individuals. VEGF levels were significantly higher than those of control samples in pleural effusions secondary to breast, mesothelioma, and non-small cell lung cancer and when all malignant pleural effusion samples were pooled. Neither interleukin-8 nor angiogenin levels were elevated in malignant pleural effusions relative to the control samples. Vascular permeability, which was measured by using the Miles assay in nude mice, was increased proportionately with VEGF levels in the malignant pleural effusions; this increase in permeability induced by injection of recombinant VEGF or the malignant effusions was reduced by pretreating the mice with a VEGF receptor antibody.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10589746

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  46 in total

Review 1.  Switching off malignant pleural effusion formation-fantasy or future?

Authors:  Magda Spella; Anastasios D Giannou; Georgios T Stathopoulos
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

Review 2.  Pleural involvement in lung cancer.

Authors:  Theodora Agalioti; Anastasios D Giannou; Georgios T Stathopoulos
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

3.  Establishment of a malignant pleural effusion mouse model: pathogenesis pathways.

Authors:  Kalliopi Domvri; Paul Zarogoulidis; Fotis Theodoropoulos; Haidong Huang; Konstantinos Zarogoulidis
Journal:  Transl Lung Cancer Res       Date:  2012-09

4.  A potential role for VEGF in the diagnostic approach of pleural effusions.

Authors:  Aggeliki Psatha; Demosthenes Makris; Theodora Kerenidi; Zoe Daniil; Theodoros Kiropoulos; Konstantinos Gourgoulianis
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

5.  Angiogenic factors and angiogenesis inhibitors in exudative pleural effusions.

Authors:  Eva Ruiz; Carmen Alemán; José Alegre; Jasone Monasterio; Rosa Ma Segura; Lluis Armadans; Ana Vázquez; Teresa Soriano; Tomás Fernández de Sevilla
Journal:  Lung       Date:  2005 May-Jun       Impact factor: 2.584

6.  Prognostic and predictive value of serum vascular endothelial growth factor (VEGF) in squamous cell carcinoma of the head and neck.

Authors:  Bijan Khademi; Mehdi Soleimanpour; Abbas Ghaderi; Mohammad Mohammadianpanah
Journal:  Oral Maxillofac Surg       Date:  2013-03-03

7.  Olecranon bursitis in patients treated with sunitinib for renal cell carcinoma.

Authors:  Thomas Gregory; Olivier Mir; Jacques Medioni; Bernard Augereau; Stéphane Oudard
Journal:  Med Oncol       Date:  2009-05-15       Impact factor: 3.064

8.  Therapeutic effects of recombinant human endostatin adenovirus in a mouse model of malignant pleural effusion.

Authors:  Fang Fang; Ping Chen; Xin Wu; Li Yang; Xun Yang; Zhen-Xiang Xi; Bin-Wen Zhou; Xi-Kun Zhou; Zhi-Yong Qian; Bo Xiao; Yu-Quan Wei
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-15       Impact factor: 4.553

9.  VEGF promotes malaria-associated acute lung injury in mice.

Authors:  Sabrina Epiphanio; Marta G Campos; Ana Pamplona; Daniel Carapau; Ana C Pena; Ricardo Ataíde; Carla A A Monteiro; Nuno Félix; Artur Costa-Silva; Claudio R F Marinho; Sérgio Dias; Maria M Mota
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

10.  Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions.

Authors:  Stacey D Finley; Aleksander S Popel
Journal:  J Natl Cancer Inst       Date:  2013-05-13       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.